Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tepper

Showing results (351-360 of 432) with videos related to

Pageof 44
Sort By:
Cephalalgia : an International Journal of Headache|October 13, 2017
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraineEgilius Lh Spierings, Jan Lewis Brandes, David B Kudrow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 12, 2019
Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxietyAndrew M Blumenfeld, Stewart J Tepper, Lawrence D Robbins, et al.
British Journal of Cancer|November 20, 2008
Statistical strategies to improve the efficiency of molecular studies of colorectal cancer prognosisP Qu, H Chu, J G Ibrahim, et al.
Physiology & Behavior|January 29, 2017
Sensory perception of and salivary protein response to astringency as a function of the 6-n-propylthioural (PROP) bitter-taste phenotypeMelania Melis, Neeta Y Yousaf, Mitchell Z Mattes, et al.
Headache|July 8, 2020
Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine AttacksStewart J Tepper, Raghavendra Vasudeva, John H Krege, et al.
Postgraduate Medicine|June 10, 2025
Efficacy and safety of rimegepant 75 mg for acute treatment of migraine: a pooled analysis of four randomized, placebo-controlled trialsStewart J Tepper, Jelena M Pavlovic, Shengyuan Yu, et al.
Mayo Clinic Proceedings|October 4, 2011
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatmentsStewart J Tepper, Shashidhar H Kori, Peter J Goadsby, et al.
Physiology & Behavior|September 20, 2011
Fat discrimination: a phenotype with potential implications for studying fat intake behaviors and obesityLisa C H Liang, Johannah Sakimura, Daniel May, et al.
Headache|October 3, 2020
No "Wearing-Off Effect" Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long-Term StudyAndrew M Blumenfeld, Darko M Stevanovic, Mario Ortega, et al.
Neurology and Therapy|August 5, 2023
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative ReviewAndrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, et al.
Pageof 44

Showing results (351-360 of 432) with videos related to

Sort By:
Pageof 44
Cephalalgia : an International Journal of Headache|October 13, 2017
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraineEgilius Lh Spierings, Jan Lewis Brandes, David B Kudrow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 12, 2019
Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxietyAndrew M Blumenfeld, Stewart J Tepper, Lawrence D Robbins, et al.
British Journal of Cancer|November 20, 2008
Statistical strategies to improve the efficiency of molecular studies of colorectal cancer prognosisP Qu, H Chu, J G Ibrahim, et al.
Physiology & Behavior|January 29, 2017
Sensory perception of and salivary protein response to astringency as a function of the 6-n-propylthioural (PROP) bitter-taste phenotypeMelania Melis, Neeta Y Yousaf, Mitchell Z Mattes, et al.
Headache|July 8, 2020
Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine AttacksStewart J Tepper, Raghavendra Vasudeva, John H Krege, et al.
Postgraduate Medicine|June 10, 2025
Efficacy and safety of rimegepant 75 mg for acute treatment of migraine: a pooled analysis of four randomized, placebo-controlled trialsStewart J Tepper, Jelena M Pavlovic, Shengyuan Yu, et al.
Mayo Clinic Proceedings|October 4, 2011
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatmentsStewart J Tepper, Shashidhar H Kori, Peter J Goadsby, et al.
Physiology & Behavior|September 20, 2011
Fat discrimination: a phenotype with potential implications for studying fat intake behaviors and obesityLisa C H Liang, Johannah Sakimura, Daniel May, et al.
Headache|October 3, 2020
No "Wearing-Off Effect" Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long-Term StudyAndrew M Blumenfeld, Darko M Stevanovic, Mario Ortega, et al.
Neurology and Therapy|August 5, 2023
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative ReviewAndrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, et al.
Pageof 44